CN Patent

CN117285467A — 喷雾干燥的分散体和制剂

Assigned to Rosso Oncology Co · Expires 2023-12-26 · 2y expired

What this patent protects

本发明涉及喷雾干燥的分散体和制剂。公开了(S)‑5‑氨基‑3‑(4‑((5‑氟‑2‑甲氧基苯甲酰胺基)甲基)苯基)‑1‑(1,1,1‑三氟丙‑2‑基)‑1H‑吡唑‑4‑甲酰胺、其药学上可接受的盐或其组合的喷雾干燥的分散体和药物组合物，以及所述喷雾干燥的分散体和药物组合物在治疗癌症和自身免疫和炎性疾病中的用途。还提供了还可用于治疗癌症和自身免疫和炎性疾病的(S)‑5‑氨基‑3‑(4‑((5‑氟‑2‑甲氧基苯甲酰胺基)甲基)苯基)‑1‑(1,1,1‑三氟丙‑2‑基)‑1H‑吡唑‑4‑甲酰胺的结晶形式。

USPTO Abstract

本发明涉及喷雾干燥的分散体和制剂。公开了(S)‑5‑氨基‑3‑(4‑((5‑氟‑2‑甲氧基苯甲酰胺基)甲基)苯基)‑1‑(1,1,1‑三氟丙‑2‑基)‑1H‑吡唑‑4‑甲酰胺、其药学上可接受的盐或其组合的喷雾干燥的分散体和药物组合物，以及所述喷雾干燥的分散体和药物组合物在治疗癌症和自身免疫和炎性疾病中的用途。还提供了还可用于治疗癌症和自身免疫和炎性疾病的(S)‑5‑氨基‑3‑(4‑((5‑氟‑2‑甲氧基苯甲酰胺基)甲基)苯基)‑1‑(1,1,1‑三氟丙‑2‑基)‑1H‑吡唑‑4‑甲酰胺的结晶形式。

Drugs covered by this patent

Patent Metadata

Patent number: CN117285467A
Jurisdiction: CN
Classification: —
Expires: 2023-12-26
Drug substance claim: No
Drug product claim: No
Assignee: Rosso Oncology Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.